In 2001, the Marihuana Medical Access Regulations (MMAR) came into force, making medical cannabis production in Canada legal for the first time [1]. Twelve years later, the Marihuana for Medical […] Read More >>
Every day, we take for granted the medical treatments offered by our physicians for illnesses like hypertension and epilepsy. If medical professionals and the pharmaceutical industry did not invest in […] Read More >>
Update (June 28, 2018): Cannabis is added to Schedule II of the Natural Health Product Regulations. Contact us for further information. 1-866-647-3279 or info@dicentra.com. Update (June 28, 2018): CBD as […] Read More >>
To comply with Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) Good Production Practices (GPP), it is mandatory to report details of all adverse reactions. An adverse drug reaction, […] Read More >>
Defining Term ‘Medical Device’ What exactly is a “medical device”? This isn’t a term that is often used in everyday conversation and is a subject that most people outside of […] Read More >>
Public support for medical marijuana in Canada has grown in recent times, and along with it the corresponding industry and market potential. The demand for medical marijuana in increasing in […] Read More >>